Literature DB >> 35972519

Medial patellofemoral ligament reconstruction using nonresorbable sutures yields comparable outcomes to reconstruction with a pedicled quadriceps tendon autograft when performed in addition to bony risk factor correction.

Danko Dan Milinkovic1, Felix Zimmermann2, Peter Balcarek3,4.   

Abstract

PURPOSE: To evaluate the results for reconstruction of the medial patellofemoral ligament using synthetic nonresorbable sutures (S-MPFL-R) in comparison to MPFL-R using quadriceps tendon autograft (QT-MPFL-R) in patients undergoing simultaneous correction of anatomic risk factors for lateral patellar instability (LPI) at a minimum of 2 years of follow-up.
METHODS: Between November 2018 and June 2019, 19 patients (male/female 8/11; mean age 26 ± 7 years) underwent S-MPFL-R (FiberTape®) in combination with the correction of predisposing risk factors for LPI. The control group of 38 patients (male/female 16/22, mean age 26 ± 6 years) who underwent QT-MPFL-R was matched 1:2 by sex, age, anatomic risk factors, and concomitant surgical correction of bony risk factors. The Banff Patella Instability Instrument 2.0 (BPII 2.0) and a numerical analog scale (NAS 0-10) for patellofemoral pain and subjective knee joint function were used to assess patients' reported quality of life before and after surgery.
RESULTS: The BPII 2.0 score increased from 35.0 ± 21.7 points to 79.7 ± 13.3 points (p < 0.0001) in the S-MPRL-R group and from 44.3 ± 19.6 points to 80.9 ± 15 points (p < 0.0001) in the QT-MPFL-R group from preoperatively to postoperatively, respectively, without any significant difference between the groups. In the S-MPFL-R group and QT-MPFL-R group, 95% (18/19) and 92% (35/38) of patients, respectively, crossed the minimally clinically important difference reported for the BPII 2.0. NAS values for pain and subjective knee joint function improved significantly in both groups (p < 0.0001, p < 0.0001) without any significant difference between the groups at the final follow-up.
CONCLUSIONS: This study demonstrates that nonresorbable sutures can serve as a viable option for MPFL-R, yielding comparable outcomes compared to quadriceps tendon autograft reconstruction when performed concomitantly with the correction of anatomic risk factors for LPI. This option reduces the need for autologous tendon harvesting or the use of allografts for MPFL-R. LEVEL OF EVIDENCE: Level III.
© 2022. The Author(s).

Entities:  

Keywords:  Autograft; BPII 2.0; Bony correction; MPFL reconstruction; Risk factors; Synthetic graft

Year:  2022        PMID: 35972519     DOI: 10.1007/s00167-022-07104-1

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.114


  44 in total

1.  Saphenous neuralgia after arthroscopically assisted anterior cruciate ligament reconstruction with a semitendinosus and gracilis tendon graft.

Authors:  C Bertram; M Porsch; M H Hackenbroch; D Terhaag
Journal:  Arthroscopy       Date:  2000-10       Impact factor: 4.772

2.  Technical failure of medial patellofemoral ligament reconstruction.

Authors:  Matthew Bollier; John Fulkerson; Andy Cosgarea; Miho Tanaka
Journal:  Arthroscopy       Date:  2011-06-12       Impact factor: 4.772

Review 3.  Synthetic devices for reconstructive surgery of the cruciate ligaments: a systematic review.

Authors:  Lachlan M Batty; Cameron J Norsworthy; Nicholas J Lash; Jason Wasiak; Anneka K Richmond; Julian A Feller
Journal:  Arthroscopy       Date:  2015-01-22       Impact factor: 4.772

4.  Successful adaption of the Banff Patella Instability Instrument (BPII) 2.0 into German.

Authors:  Christoph Becher; René Attal; Peter Balcarek; Florian Dirisamer; Michael Liebensteiner; Geert Pagenstert; Philip Schöttle; Gerd Seitlinger; Daniel Wagner
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-08-07       Impact factor: 4.342

Review 5.  Results of medial patellofemoral ligament reconstruction compared with trochleoplasty plus individual extensor apparatus balancing in patellar instability caused by severe trochlear dysplasia: a systematic review and meta-analysis.

Authors:  Peter Balcarek; Stephan Rehn; Nick R Howells; Jonathan D Eldridge; Keisuke Kita; David Dejour; Manfred Nelitz; Ingo J Banke; Delphine Lambrecht; Markus Harden; Tim Friede
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10-27       Impact factor: 4.342

6.  Which patellae are likely to redislocate?

Authors:  Peter Balcarek; Swantje Oberthür; Stephanie Hopfensitz; Stephan Frosch; Tim Alexander Walde; Martin Michael Wachowski; Jan Philipp Schüttrumpf; Klaus Michael Stürmer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-05       Impact factor: 4.342

7.  Clinical outcomes of medial patellofemoral ligament repair in recurrent (chronic) lateral patella dislocations.

Authors:  Elizabeth A Arendt; Amy Moeller; Julie Agel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-04-30       Impact factor: 4.342

8.  Medial patellofemoral ligament reconstruction with bioactive synthetic ligament is an option. A 3-year follow-up study.

Authors:  Massimo Berruto; Paolo Ferrua; Francesco Uboldi; Eva Usellini; Luca Gala; Alberto Tassi; Bruno Marelli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-05       Impact factor: 4.342

9.  [Patella infera. Apropos of 128 cases].

Authors:  J Caton; G Deschamps; P Chambat; J L Lerat; H Dejour
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1982

10.  Geometry of Torsional Malalignment Syndrome: Trochlear Dysplasia but Not Torsion Predicts Lateral Patellar Instability.

Authors:  Peter Balcarek; Tobias Radebold; Xenia Schulz; Dennis Vogel
Journal:  Orthop J Sports Med       Date:  2019-03-15
View more
  1 in total

1.  Soft-tissue fixation is not inferior to suture-anchor fixation in reconstruction of the medial patellofemoral ligament using a nonresorbable suture tape.

Authors:  Felix Zimmermann; Mareike Schonhoff; Sebastian Jäger; Danko Dan Milinkovic; Jochen Franke; Paul Alfred Grützner; Peter Balcarek; Sven Vetter
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-08-22       Impact factor: 4.114

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.